Latest Breaking News On - Oncosec medical inc - Page 1 : vimarsana.com

Merkel Cell Carcinoma Treatment Market Size Poised for Remarkable Growth, to Surpass USD 6 59 billio

Merkel Cell Carcinoma Treatment Market Size Poised for Remarkable Growth, to Surpass USD 6 59 billio
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesNew yorkAsia pacificLawrence johnBeigene ltdDesign corpMerck kgaaJohnson privateAmgen incResearch activitiesMerck kgaMillennium pharmaceuticals incMerck coPrudour pvt ltdDigital health integration

Nutter Securities Enforcement Update: June 1, 2023 | Nutter McClennen & Fish LLP

The Nutter Securities Enforcement Update is a periodic summary of noteworthy recent securities enforcement activity, settlements, decisions, and charges.

United statesUnited kingdom generalUnited kingdomDominican republicBrian amoahBrasil ressegurosCedric dewayne griffinThomas carter ronkLee cohenIsaach suttonElbert al elliottJoshua burrellMatthewj wertheShrizalif jumaniArthur mikaelianRonald swanson

StockNews com Initiates Coverage on OncoSec Medical (NASDAQ:ONCS)

StockNews.com assumed coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a report issued on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock. OncoSec Medical Stock Down 7.1 % Shares of ONCS opened at $0.20 on Friday. OncoSec Medical has a 12-month low of $0.18 and a 12-month high […]

York mellon corpRenaissance technologiesInvestment advisersOncosec medical incOncosec medicalGet ratingSec medical stock downSigma investmentsNew york mellon corpSec medicalOncosec medical dailyNasdaq oncsInitiated coverageStocknews com

105,690 Shares in OncoSec Medical Incorporated (NASDAQ:ONCS) Purchased by FNY Investment Advisers LLC

FNY Investment Advisers LLC acquired a new position in OncoSec Medical Incorporated (NASDAQ:ONCS – Get Rating) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 105,690 shares of the biotechnology company’s stock, valued at approximately $272,000. FNY Investment Advisers LLC owned approximately 3.56% of […]

Renaissance technologiesFny investment advisersYork mellon corpOncosec medical incInvestment advisersOncosec medical incorporatedExchange commissionGet ratingOncosec medicalNew york mellon corpTwo sigma investmentsSec medical stock downSec medicalOncosec medical daily

StockNews com Begins Coverage on OncoSec Medical (NASDAQ:ONCS)

StockNews.com began coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a research note published on Sunday morning. The brokerage issued a sell rating on the biotechnology company’s stock. OncoSec Medical Stock Performance Shares of NASDAQ ONCS opened at $0.21 on Friday. The stock has a fifty day moving average price of $0.65 […]

Oncosec medical incYork mellon corpInvestment advisersRenaissance technologiesOncosec medicalGet ratingSec medicalNew york mellon corpTwo sigma investmentsOncosec medical dailyNasdaq oncsInitiated coverageStocknews com